{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:11:56Z","timestamp":1791922316288,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T00:00:00Z","timestamp":1490054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006636","name":"Forskningsr\u00e5det om H\u00e4lsa, Arbetsliv och V\u00e4lf\u00e4rd","doi-asserted-by":"publisher","award":["2014-4699"],"award-info":[{"award-number":["2014-4699"]}],"id":[{"id":"10.13039\/501100006636","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","amjmed.com","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.amjmed.2017.02.028","type":"journal-article","created":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T20:45:51Z","timestamp":1493153151000},"page":"927-936.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Choosing Wisely? Measuring the Burden of Medications in Older Adults near the End of Life: Nationwide, Longitudinal Cohort Study"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8486-8610","authenticated-orcid":false,"given":"Lucas","family":"Morin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide L.","family":"Vetrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Rizzuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaia","family":"Calder\u00f3n-Larra\u00f1aga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Fastbom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Johnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9836","key":"10.1016\/j.amjmed.2017.02.028_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","article-title":"Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study","volume":"380","author":"Barnett","year":"2012","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.amjmed.2017.02.028_bib2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2165\/00002018-200730100-00009","article-title":"The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register","volume":"30","author":"Johnell","year":"2007","journal-title":"Drug Saf"},{"issue":"17","key":"10.1016\/j.amjmed.2017.02.028_bib3","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999-2012","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.amjmed.2017.02.028_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/bmjspcare-2014-000767","article-title":"Analysis of drug interactions at the end of life","volume":"5","author":"Morgan","year":"2015","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.amjmed.2017.02.028_bib5","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/j.1532-5415.2008.01741.x","article-title":"Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use","volume":"56","author":"Holmes","year":"2008","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.amjmed.2017.02.028_bib6","article-title":"Inappropriate prescribing of preventative medication in patients with life-limiting illness: a systematic review","author":"Todd","year":"2016","journal-title":"BMJ Support Palliat Care"},{"issue":"4","key":"10.1016\/j.amjmed.2017.02.028_bib7","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00520-012-1619-0","article-title":"Variation in medication use in cancer patients at the end of life: a cross-sectional analysis","volume":"21","author":"Raijmakers","year":"2013","journal-title":"Support Care Cancer"},{"issue":"4","key":"10.1016\/j.amjmed.2017.02.028_bib8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1089\/jpm.2012.0158","article-title":"Statin prescribing patterns in a cohort of cancer patients with poor prognosis","volume":"16","author":"Bayliss","year":"2013","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.amjmed.2017.02.028_bib9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00520-008-0541-y","article-title":"Futile medication use in terminally ill cancer patients","volume":"17","author":"Riechelmann","year":"2009","journal-title":"Support Care Cancer"},{"issue":"11","key":"10.1016\/j.amjmed.2017.02.028_bib10","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jamainternmed.2014.4103","article-title":"Use of medications of questionable benefit in advanced dementia","volume":"174","author":"Tjia","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"8","key":"10.1016\/j.amjmed.2017.02.028_bib11","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/1049909113506981","article-title":"Noncomfort medication use in acute care inpatients comanaged by palliative care specialists near the end of life: a cohort study","volume":"31","author":"Ma","year":"2014","journal-title":"Am J Hosp Palliat Care"},{"issue":"6","key":"10.1016\/j.amjmed.2017.02.028_bib12","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jamda.2016.01.015","article-title":"Changes in prescribed drugs between admission and the end of life in patients admitted to palliative care facilities","volume":"17","author":"van Nordennen","year":"2016","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"11","key":"10.1016\/j.amjmed.2017.02.028_bib13","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1111\/jgs.13795","article-title":"Medications that older adults in hospice care in the United States take, 2007","volume":"63","author":"Dwyer","year":"2015","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.amjmed.2017.02.028_bib14","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1111\/ajag.12220","article-title":"Medication use and potentially inappropriate medications in those with limited prognosis living in residential aged care","volume":"35","author":"Heppenstall","year":"2016","journal-title":"Australas J Ageing"},{"issue":"2","key":"10.1016\/j.amjmed.2017.02.028_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jpainsymman.2015.09.003","article-title":"The burden of polypharmacy in patients near the end of life","volume":"51","author":"McNeil","year":"2016","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"4","key":"10.1016\/j.amjmed.2017.02.028_bib16","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00520-015-2970-8","article-title":"Polypharmacy cut-points in older people with cancer: how many medications are too many?","volume":"24","author":"Turner","year":"2016","journal-title":"Support Care Cancer"},{"issue":"9","key":"10.1016\/j.amjmed.2017.02.028_bib17","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jclinepi.2012.02.018","article-title":"Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes","volume":"65","author":"Gnjidic","year":"2012","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"6","key":"10.1016\/j.amjmed.2017.02.028_bib18","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/gerona\/glr233","article-title":"Polypharmacy in nursing home in Europe: results from the SHELTER study","volume":"67","author":"Onder","year":"2012","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"10.1016\/j.amjmed.2017.02.028_bib19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.7326\/M13-1609","article-title":"Symptom trends in the last year of life from 1998 to 2010: a cohort study","volume":"162","author":"Singer","year":"2015","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.amjmed.2017.02.028_bib20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0895-4356(97)00040-1","article-title":"Validation of pharmacy records in drug exposure assessment","volume":"50","author":"Lau","year":"1997","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.amjmed.2017.02.028_bib21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s40266-012-0002-7","article-title":"Comparison of prescription drug use between community-dwelling and institutionalized elderly in Sweden","volume":"29","author":"Johnell","year":"2012","journal-title":"Drugs Aging"},{"issue":"7498","key":"10.1016\/j.amjmed.2017.02.028_bib22","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/bmj.330.7498.1007","article-title":"Illness trajectories and palliative care","volume":"330","author":"Murray","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2017.02.028_bib23","article-title":"Estimating the need for palliative care at the population level: a cross-national study in 12 countries","author":"Morin","year":"2016","journal-title":"Palliat Med"},{"issue":"18","key":"10.1016\/j.amjmed.2017.02.028_bib24","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1001\/jama.289.18.2387","article-title":"Patterns of functional decline at the end of life","volume":"289","author":"Lunney","year":"2003","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.amjmed.2017.02.028_bib25","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1001\/jamainternmed.2013.8732","article-title":"Restricting symptoms in the last year of life: a prospective cohort study","volume":"173","author":"Chaudhry","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.amjmed.2017.02.028_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/glw233","article-title":"Assessing and measuring chronic multimorbidity in the older population: a proposal for its operationalization","author":"Calder\u00f3n-Larra\u00f1aga","year":"2016","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"10.1016\/j.amjmed.2017.02.028_bib27","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s00520-015-3007-z","article-title":"Polypharmacy in the terminal stage of cancer","volume":"24","author":"Kierner","year":"2016","journal-title":"Support Care Cancer"},{"issue":"7","key":"10.1016\/j.amjmed.2017.02.028_bib28","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1016\/S1470-2045(15)00080-7","article-title":"Polypharmacy in patients with advanced cancer and the role of medication discontinuation","volume":"16","author":"LeBlanc","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.amjmed.2017.02.028_bib29","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/bmj.329.7471.909","article-title":"Managing comorbidities in patients at the end of life","volume":"329","author":"Stevenson","year":"2004","journal-title":"Br Med J"},{"issue":"5","key":"10.1016\/j.amjmed.2017.02.028_bib30","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1089\/jpm.2007.0215","article-title":"Statins in the last six months of life: a recognizable, life-limiting condition does not decrease their use","volume":"11","author":"Silveira","year":"2008","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.amjmed.2017.02.028_bib31","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/jama.2014.10924","article-title":"Evaluation and treatment of older patients with hypercholesterolemia: a clinical review","volume":"312","author":"Strandberg","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.amjmed.2017.02.028_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1179\/174329111X576698","article-title":"Preventive medication use among persons with limited life expectancy","volume":"19","author":"Maddison","year":"2011","journal-title":"Prog Palliat Care"},{"issue":"7115","key":"10.1016\/j.amjmed.2017.02.028_bib33","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/bmj.315.7115.1096","article-title":"Optimising drug treatment for elderly people: the prescribing cascade","volume":"315","author":"Rochon","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2017.02.028_bib34","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/archinte.166.6.605","article-title":"Reconsidering medication appropriateness for patients late in life","volume":"166","author":"Holmes","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2017.02.028_bib35","doi-asserted-by":"crossref","first-page":"g7013","DOI":"10.1136\/bmj.g7013","article-title":"Discontinuing drug treatments","volume":"349","author":"Gnjidic","year":"2014","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.amjmed.2017.02.028_bib36","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.amjmed.2017.02.028_bib37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cger.2012.01.006","article-title":"Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes","volume":"28","author":"Gnjidic","year":"2012","journal-title":"Clin Geriatr Med"},{"issue":"5","key":"10.1016\/j.amjmed.2017.02.028_bib38","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jamainternmed.2015.0289","article-title":"Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial","volume":"175","author":"Kutner","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1016\/j.amjmed.2017.02.028_bib39","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1177\/1060028016637181","article-title":"Deprescribing potentially inappropriate preventive cardiovascular medication: barriers and enablers for patients and general practitioners","volume":"50","author":"Luymes","year":"2016","journal-title":"Ann Pharmacother"},{"issue":"8","key":"10.1016\/j.amjmed.2017.02.028_bib40","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s40266-016-0384-z","article-title":"Withdrawal of antidementia drugs in older people: who, when and how?","volume":"33","author":"Parsons","year":"2016","journal-title":"Drugs Aging"},{"issue":"15","key":"10.1016\/j.amjmed.2017.02.028_bib41","first-page":"1","article-title":"Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses","volume":"4422","author":"Howard","year":"2015","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1016\/j.amjmed.2017.02.028_bib42","doi-asserted-by":"crossref","first-page":"e0161407","DOI":"10.1371\/journal.pone.0161407","article-title":"A\u00a0systematic review of predictions of survival in palliative care: how accurate are clinicians and who are the experts?","volume":"11","author":"White","year":"2016","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.amjmed.2017.02.028_bib43","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1056\/NEJMp1516803","article-title":"The science of choosing wisely\u2013overcoming the therapeutic illusion","volume":"374","author":"Casarett","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjmed.2017.02.028_bib44","first-page":"d1933","article-title":"Understanding provision of chemotherapy to patients with end stage cancer: qualitative interview study","volume":"342","author":"Buiting","year":"2011","journal-title":"Br Med J"},{"issue":"3","key":"10.1016\/j.amjmed.2017.02.028_bib45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.2015.19206","article-title":"Quantity and quality of life: duties of care in life-limiting illness","volume":"315","author":"Gawande","year":"2016","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.amjmed.2017.02.028_bib46","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s40266-014-0182-4","article-title":"Decision making about change of medication for comorbid disease at the end of life: an integrative review","volume":"31","author":"Van Nordennen","year":"2014","journal-title":"Drugs Aging"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293431730253X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293431730253X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T15:58:30Z","timestamp":1747843110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293431730253X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S000293431730253X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2017.02.028","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Choosing Wisely? Measuring the Burden of Medications in Older Adults near the End of Life: Nationwide, Longitudinal Cohort Study","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2017.02.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2017.03.012","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}